Martin Shkreli Resigns From Turing Pharmaceuticals Following Arrest
One day after he was arrested on suspicions of security fraud, Martin Shkreli has resigned from his position as CEO of Turing Pharmaceuticals.
At Turing, Shkreli made headlines after he had notoriously jacked up prices of the life-saving drug Daraprim and jacking its price up from $13.50 to $750 per tablet. Ron Tilles, the chairman of Turing’s board of directors, will step in as CEO on an interim basis, according to NBC.
46m
7m
3m
22m
59m
8m
4m
1m
1m
1m
1m
41s
1m
1m
2m
9m
2m
16m
8m
30s
9m
21m
20m
56m
41m
1h 30m
1h 34m
2m
1h 42m
58m
47m
2m
20m
1m
2m
1h 25m
1h 25m
2m
1h 36m
1h 25m
22m
8m
1m
1h 7m
2m
1h 36m
57m
20m
1m
51m
42m
1h 17m
59s
1m
41m
22m
1h 38m
20m
7m
30s